343 related articles for article (PubMed ID: 31213534)
21. Glycosylation and Integrin Regulation in Cancer.
Marsico G; Russo L; Quondamatteo F; Pandit A
Trends Cancer; 2018 Aug; 4(8):537-552. PubMed ID: 30064662
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
[TBL] [Abstract][Full Text] [Related]
23. Colonic carcinogenesis along different genetic routes: glycophenotyping of tumor cases separated by microsatellite instability/stability.
Gebert J; Kloor M; Lee J; Lohr M; André S; Wagner R; Kopitz J; Gabius HJ
Histochem Cell Biol; 2012 Aug; 138(2):339-50. PubMed ID: 22565205
[TBL] [Abstract][Full Text] [Related]
24. Sugar recognition and protein-protein interaction of mammalian lectins conferring diverse functions.
Nagae M; Yamaguchi Y
Curr Opin Struct Biol; 2015 Oct; 34():108-15. PubMed ID: 26418728
[TBL] [Abstract][Full Text] [Related]
25. The cancer glycome: carbohydrates as mediators of metastasis.
Glavey SV; Huynh D; Reagan MR; Manier S; Moschetta M; Kawano Y; Roccaro AM; Ghobrial IM; Joshi L; O'Dwyer ME
Blood Rev; 2015 Jul; 29(4):269-79. PubMed ID: 25636501
[TBL] [Abstract][Full Text] [Related]
26. CBS homogenization mutation strategy narrows the glycan binding profile of a GlcNAc-specific lectin AANL.
Su Y; Ye X; Xu B; Li Y; Yang Q; Yu W; Song J; Guo C; Wang X; Hart GW; Sun H
Glycobiology; 2020 Feb; 30(3):159-173. PubMed ID: 31616917
[TBL] [Abstract][Full Text] [Related]
27. Sensing Glycans as Biochemical Messages by Tissue Lectins: The Sugar Code at Work in Vascular Biology.
Kaltner H; Gabius HJ
Thromb Haemost; 2019 Apr; 119(4):517-533. PubMed ID: 30620995
[TBL] [Abstract][Full Text] [Related]
28. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
29. Targeting Aberrant Sialylation to Treat Cancer.
Munkley J; Scott E
Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31614918
[TBL] [Abstract][Full Text] [Related]
30. Galectin-Glycan Interactions as Regulators of B Cell Immunity.
Giovannone N; Smith LK; Treanor B; Dimitroff CJ
Front Immunol; 2018; 9():2839. PubMed ID: 30564237
[TBL] [Abstract][Full Text] [Related]
31. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
32. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.
Potapenko IO; Haakensen VD; Lüders T; Helland A; Bukholm I; Sørlie T; Kristensen VN; Lingjaerde OC; Børresen-Dale AL
Mol Oncol; 2010 Apr; 4(2):98-118. PubMed ID: 20060370
[TBL] [Abstract][Full Text] [Related]
33. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
[TBL] [Abstract][Full Text] [Related]
34. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
35. Glycans and Glycan-Binding Proteins in Atherosclerosis.
Eckardt V; Weber C; von Hundelshausen P
Thromb Haemost; 2019 Aug; 119(8):1265-1273. PubMed ID: 31266083
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
37. Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.
Kizuka Y; Taniguchi N
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136596
[TBL] [Abstract][Full Text] [Related]
38. Role of tumor cell sialylation in pancreatic cancer progression.
Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
[TBL] [Abstract][Full Text] [Related]
39. Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Orozco-Moreno M; Visser EA; Hodgson K; Hipgrave Ederveen AL; Bastian K; Goode EA; Öztürk Ö; Pijnenborg JFA; Eerden N; Moons SJ; Rossing E; Wang N; de Haan N; Büll C; Boltje TJ; Munkley J
Glycobiology; 2023 Dec; 33(12):1155-1171. PubMed ID: 37847613
[TBL] [Abstract][Full Text] [Related]
40. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
Pearson AJ; Gallagher ES
Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
